Showing 1 - 2 results of 2 for search 'Lina Asmar', query time: 0.01s Refine Results
  1. 1
    TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY

    TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY by Rola Husni, Remie Chrabieh, Rita Wilson Dib, Jose Vazquez, MD, Thaís Guimarães, Ana Fernández, Rita Khoury, Lina Asmar, Georges Khazen, Nadia Lara Samaha, Issam Raad, Ray Hachem

    Published 2021-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

    Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive... by Frankie Ann Holmes, Beth A. Hellerstedt, John E. Pippen Jr., Svetislava J. Vukelja, Rufus P. Collea, Darren M. Kocs, Joanne L. Blum, Kristi J. McIntyre, Minal A. Barve, Barry D. Brooks, Cynthia R. Osborne, Yunfei Wang, Lina Asmar, Joyce O'Shaughnessy

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: